Agios Pharmaceuticals | AGIO - Stock


Agios Pharmaceuticals reported $32.92M in Stock for its fiscal quarter ending in December of 2025.





Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Alnylam Pharmaceuticals USD 82.72M 7.34M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Astellas Pharma JPY 297.26B 9.92B Mar/2025
AstraZeneca USD 6.59B 126M Sep/2025
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Exelixis USD 27.4M 3.92M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025